Mahmoud Ameri
16Patents
7h-index
11Co-inventors
59Inventor score
Filing activity: Jun 29, 2004 → May 25, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7556821B2 | Apparatus and method for transdermal delivery of parathyroid hormone agents | Human Necessities | 39 | Expired |
| US8361022B2 | Apparatus for transdermal delivery of parathyroid hormone agents | Human Necessities | 26 | Active |
| US8920817B2 | Formulations for coated microprojections containing non-volatile counterions | Emerging Cross-Sectional Technologies | 21 | Active |
| US7579013B2 | Formulations for coated microprojections containing non-volatile counterions | Emerging Cross-Sectional Technologies | 17 | Expired |
| US8632801B2 | Stable therapeutic formulations | Emerging Cross-Sectional Technologies | 12 | Active |
| US8633159B2 | Apparatus and method for transdermal delivery of parathyroid hormone agents | Human Necessities | 8 | Active |
| US9295714B2 | Apparatus and method for transdermal delivery of parathyroid hormone agents | Human Necessities | 8 | Active |
| US9918932B2 | Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines | Human Necessities | 4 | Active |
| US9782344B2 | Stable glucagon peptide formulations | Human Necessities | 4 | Active |
| US11058630B2 | Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines | Human Necessities | 3 | Active |
| US9573717B2 | Stable therapeutic formulations | Emerging Cross-Sectional Technologies | 2 | Active |
| US9173924B2 | Stable glucagon peptide formulations | Human Necessities | 1 | Active |
| US11839683B2 | Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines | Human Necessities | 0 | Active |
| US11660265B2 | Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines and cluster headaches | Performing Operations; Transporting | 0 | Active |
| US11179324B2 | Stable therapeutic formulations | Emerging Cross-Sectional Technologies | 0 | Active |
| US11660264B2 | Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines and cluster headaches | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.